Why Do Patients Develop Proteinuria With Sirolimus? Do We Have the Answer?
Refers to article:
Tubular Toxicity in Sirolimus- and Cyclosporine-Based Transplant Immunosuppression Strategies: An Ancillary Study From a Randomized Controlled Trial
, 18 November 2009
Stefan Franz, Axel Regeniter, Helmut Hopfer, Michael Mihatsch, Michael Dickenmann
American Journal of Kidney Diseases
February 2010 (Vol. 55, Issue 2, Pages 335-343) Abstract |
Full Text |
Full-Text PDF (563 KB)
No abstract is available. To read the body of this article, please view the Full Text online.
Westmead Hospital, Sydney, Australia
Address correspondence to Jeremy R. Chapman, MD, Department of Renal Medicine, Westmead Hospital, Westmead, Sydney, NSW 2145 Australia
